Wells Fargo & Company Amgen Inc Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Amgen Inc stock. As of the latest transaction made, Wells Fargo & Company holds 7,490,180 shares of AMGN stock, worth $2.08 Billion. This represents 0.56% of its overall portfolio holdings.

Number of Shares

7,490,180

Previous 7,677,589 2.44%

Holding current value

$2.08 Billion

Previous $2.4 Billion 0.61%

% of portfolio

0.56%

Previous 0.59%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$309.38 - $337.38 $58 Million - $63.2 Million	-187,409 Reduced 2.44%	7,490,180 $2.41 Billion
Q2 2024 Aug 13, 2024	BUY	$262.75 - $319.31 $46 Million - $55.8 Million	174,907 Added 2.33%	7,677,589 $2.4 Billion
Q1 2024 May 10, 2024	BUY	$268.87 - $324.56 $3.74 Million - $4.51 Million	13,905 Added 0.19%	7,502,682 $2.13 Billion
Q4 2023 Feb 09, 2024	SELL	$255.7 - $288.46 $23.7 Million - $26.7 Million	-92,642 Reduced 1.22%	7,488,777 $2.16 Billion
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $19.5 Million - $24.2 Million	-89,294 Reduced 1.16%	7,581,419 $2.04 Billion
Q2 2023 Aug 15, 2023	BUY	$214.27 - $253.37 $21.1 Million - $24.9 Million	98,374 Added 1.3%	7,670,713 $1.7 Billion
Q1 2023 May 12, 2023	BUY	$225.79 - $275.2 $40.4 Million - $49.3 Million	178,976 Added 2.42%	7,572,339 $1.83 Billion
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $23.5 Million - $29.9 Million	-102,594 Reduced 1.37%	7,393,363 $1.94 Billion
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $2.9 Million - $3.28 Million	-12,942 Reduced 0.17%	7,495,957 $1.69 Billion
Q2 2022 Aug 12, 2022	SELL	$230.71 - $256.74 $22.7 Million - $25.3 Million	-98,549 Reduced 1.3%	7,508,899 $1.83 Billion
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $207 Million - $229 Million	944,683 Added 14.18%	7,607,448 $1.84 Billion
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $53.6 Million - $61.4 Million	-269,747 Reduced 3.89%	6,662,765 $1.5 Billion
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $41.4 Million - $48.5 Million	-195,083 Reduced 2.74%	6,932,512 $1.47 Billion
Q2 2021 Aug 16, 2021	SELL	$233.58 - $259.14 $119 Million - $132 Million	-511,012 Reduced 6.69%	7,127,595 $1.74 Billion
Q1 2021 May 13, 2021	BUY	$221.91 - $258.6 $5.66 Million - $6.59 Million	25,489 Added 0.33%	7,638,607 $1.9 Billion
Q4 2020 Feb 09, 2021	BUY	$216.38 - $257.67 $42.1 Million - $50.1 Million	194,587 Added 2.62%	7,613,118 $1.75 Billion
Q3 2020 Nov 05, 2020	SELL	$234.65 - $260.95 $7.31 Million - $8.13 Million	-31,153 Reduced 0.42%	7,418,531 $1.89 Billion
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $54.7 Million - $67.1 Million	276,284 Added 3.85%	7,449,684 $1.76 Billion
Q1 2020 May 14, 2020	BUY	$182.24 - $241.7 $1.31 Billion - $1.73 Billion	7,173,400 New	7,173,400 $1.45 Billion

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Amgen Inc Transaction History